|
業務類別
|
Biotechnology |
|
業務概覽
|
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications. |
| 公司地址
| 8, rue de la Croix Jarry, Paris, FRA, 75013 |
| 電話號碼
| +33 181691600 |
| 傳真號碼
| +33 181691606 |
| 公司網頁
| https://www.cellectis.com |
| 員工數量
| 222 |
| Dr. Philippe Duchateau, PhD |
Chief Scientific Officer |
-- |
14/03/2025 |
| Ms. Kyung Nam-Wortman |
Executive Vice President and Chief Human Resources Officer |
-- |
14/03/2025 |
| Mr. Arthur Stril |
Chief Financial Officer and Chief Business Officer |
-- |
14/03/2025 |
| Ms. Marie-Bleuenn Terrier |
General Counsel |
-- |
14/03/2025 |
| Mr. Stephan Reynier |
Chief Regulatory and Pharmaceutical Compliance Officer |
-- |
14/03/2025 |
| Dr. David Sourdive, PhD |
Director, Deputy Chief Executive Officer and Executive Vice President, CMC and Manufacturing |
美元 593.16K |
14/03/2025 |
| Dr. Andre Choulika, PhD |
Director and Chief Executive Officer |
美元 937.54K |
14/03/2025 |
| Dr. Adrian Kilcoyne, M.B.A.,M.D.,M.P.H. |
Chief Medical Officer |
-- |
14/03/2025 |
| Dr. Steven Doares, PhD |
Senior Vice President, US Manufacturing |
-- |
14/03/2025 |
|
|
| Dr. Donald A. Bergstrom, M.D.,PhD |
Independent Director |
14/03/2025 |
| Dr. Cecile Chartier, PhD |
Independent Director |
14/03/2025 |
| Mr. Rainer J. Boehm, M.B.A. |
Independent Director |
14/03/2025 |
| Dr. Tyrell J. Rivers, PhD |
Director |
14/03/2025 |
| Dr. David Sourdive, PhD |
Director, Deputy Chief Executive Officer and Executive Vice President, CMC and Manufacturing |
14/03/2025 |
| Dr. Andre Choulika, PhD |
Director and Chief Executive Officer |
14/03/2025 |
| Mr. Laurent Arthaud |
Independent Director |
14/03/2025 |
| Mr. Pierre Tristan Michel Bastid |
Independent Director |
14/03/2025 |
| Mr. Marc Dunoyer |
Director |
14/03/2025 |
| Dr. Jean-Pierre Garnier, PhD |
Chairman of the Board |
14/03/2025 |
| Mr. Axel-Sven Malkomes |
Independent Director |
14/03/2025 |
|
|
|
|
